As our knowledge of the basis of different cancers grows, so does the arsenal of specific weapons with which to fight the disease (pages 792–797).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bishop, J.M. Molecular themes in oncogenesis. Cell 64, 235–248 (1991).
Kohl, N.E. et al. Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice. Nature Med. 1, 792–797 (1995).
Lowy, D.R. & Willumsen, B.M. Function and regulation of Ras. Annu. Rev. Biochem. 62, 851–891 (1993).
Bos, J.L. ras oncogenes in human cancer: A review. Cancer Res. 49, 4682–4689 (1989).
Stacey, D.W., DeGudicibus, S.R. & Smith, M.R., ras activity and tumor cell proliferation. Exp. cell Res. 171, 232–242 (1987).
Gibbs, J.B., Oliff, A. & Kohl, N.E. Farnesyltransferase inhibitors - Ras research yields a potential cancer therapeutic. Cell 77, 175–178 (1994).
Reiss, Y., Goldstein, J.L., Seabra, M.C., Casey, P.J. & Brown, M.S. Inhibition of purified p21 ras famesyl-protein transferase by Cys-AAX tetrapeptides. Cell 62, 81–88 (1990).
Kohl, N.E. et al. Selective inhibition of Ras-dependent transformation by a farnesyltransferase inhibitor. Science 260, 1934–1937 (1993).
James, G.L. et al. Benzodiazepine peptidomimetics — potent inhibitors of ras farnesylation in animal cells. Science 260, 1937–1942 (1993).
Manne, V. et al. Bisubstrate inhibitors of farnesyltransferase: a novel class of specific inhibitors of ras transformed cells. Oncogene 10, 1763–1779 (1995).
Kohl, N.E. et al. Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice. Proc. natn. Acad. Sci. U.S.A. 91, 9141–9145 (1994).
Cox, A.D. et al. The CAAX peptidomimetic compound b581 specifically blocks farnesylated, but not geranylgeranylated or myristylated, oncogenic ras signaling and transformation. J. biol. Chem. 269, 19203–19206 (1994).
Jordan, V.C. The role of tamoxifen in the treatment and prevention of breast cancer. Curr. Prob. Cancer 16, 129–176 (1992).
Dexter, D.D., Diamond, M., Crevling, J. & Chen, S.-F. Chemotherapy of mammary carcinomas arising in transgenic mice. Invest. New Drugs 11, 161–168 (1993).
Prendergast, G.C. et al. Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton. Molec. cell. Biol. 14, 4193–4202 (1994).
James, G.L., Goldstein, J.L. & Brown, M.S. Polylysine and CVIM sequences of K-RasB dictate specificity of prenylation and confer resistance to benzodiazepine peptidomimetic in vitro. J. biol Chem. 270, 6221–6226 (1995).
James, G.L., Brown, M.S., Cobb, M.H. & Goldstein, J.L. Benzodiazepine peptidomimetic BZA-5B interrupts the MAP kinase activation pathway in H-Ras-transformed rat-1 cells, but not in untransformed cells. J. biol Chem. 269, 27705–27714 (1994).
Mulcahy, L.S., Smith, M.R. & Stacey, D.W. Requirements for ras proto-oncogene function during serum stimulated growth of NIH 3T3 cells. Nature 313, 241–243 (1985).
Papageorge, A.G. et al. A transforming ras gene can provide an essential function ordinarily supplied by an endogenous ras gene. Molec. cell Biol 6, 1843–1846 (1986).
Stacey, D.W., Feig, L.A. & Gibbs, J.B. Dominant inhibitory Ras mutants selectively inhibit the activity of either cellular or oncogenic Ras. Molec. cell. Biol. 11, 4053–4064 (1991).
Vaziri, C. & Faller, D.V. Repression of platelet-derived growth factor beta-receptor expression by mitogenic growth factors and transforming oncogenes in murine 3T3 fibroblasts. Molec. cell. Biol. 15, 1244–1253 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lowy, D., Willumsen, B. Rational cancer therapy. Nat Med 1, 747–748 (1995). https://doi.org/10.1038/nm0895-747
Issue Date:
DOI: https://doi.org/10.1038/nm0895-747
This article is cited by
-
Oncogenes as inducers of tumor angiogenesis
Cancer and Metastasis Reviews (1995)